Toxoplasmosis of the central nervous system in non-human immunodeficiency virus-infected children: Case report and review of the literature

Pediatric Infectious Disease Journal

Volumn 16, Issue 6, 1997, Pages 611-618

  Khan, Ejaz A ^a   Correa, Armando G ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Acquired toxoplasmosis; Central nervous system toxoplasmosis; Immunocompromised host; Toxoplasma encephalitis

Indexed keywords

ARTICLE; CHILD; CRANIAL NEUROPATHY; FEVER; HEMIPARESIS; HEMIPLEGIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MUSCLE WEAKNESS; PRIORITY JOURNAL; TOXOPLASMOSIS;

CHILD; HUMANS; MALE; TOXOPLASMOSIS, CEREBRAL;

EID: 0030990653     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199706000-00013     Document Type: Article

References (62)

1. Remington JS, McLeod R, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. 4th ed. Philadelphia: Saunders, 1995: 140-267.
2. Hedenström G, Huldt G, Lagercrantz R. Toxoplasmosis in children: a study of 83 Swedish cases. Acta Paediatr 1961;50: 304-12.
3. Feldman HA. Toxoplasmosis. N Engl J Med 1968;279: 1370-5, 1431-7.
4. Sabin AB. Toxoplasmic encephalitis in children. Pinkerton H, Henderson RG. Adult toxoplasmosis: a previously unrecognized disease entity. JAMA 1941;116:801-7, 807-14.
5. Sabin AB. Toxoplasmic encephalitis in children. Pinkerton H, Henderson RG. Adult toxoplasmosis: a previously unrecognized disease entity. JAMA 1941;116:801-7, 807-14.
6. Ruskin J, Remington JS. Toxoplasmosis in the compromised host. Ann Intern Med 1976;84:193-9.
7. Yermakov V, Rashid RK, Vuletin JC, Pertshuk LP, Isaksson H. Disseminated toxoplasmosis: case report and review of literature. Arch Pathol Lab Med 1982;106:524-8.
8. Gleason TH, Hamlin WB. Disseminated toxoplasmosis in the compromised host: a report of five cases. Arch Intern Med 1974;134:1059-62.
9. Vietzke WM, Gelderman AH, Grimley PM, Valsamis MP. Toxoplasmosis complicating malignancy: experience at The National Cancer Institute. Cancer 1968;21:816-27.
10. Luft BJ, Brooks RG, Conley FK, McCabe RE, Remington JS. Toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome. JAMA 1984;252:913-7.
11. Luft BJ, Naot Y, Araujo FG, Stinson EB, Remington JS. Primary and reactivated Toxoplasma infection in patients with cardiac transplants. Ann Intern Med 1983;99:27-31.
12. Derouin F, Gluckman E, Beauvais B, et al. Toxoplasma infection after human allogeneic bone marrow transplantation: clinical and serological study of 80 patients. Bone Marrow Transplant 1986;1:67-73.
13. Wiznitzer M, Packer RJ, August CS, Burkey ED. Neurological complications of bone marrow transplantation in childhood. Ann Neurol 1984;16:569-76.
14. Michaels MG, Wald ER, Fricker FJ, Nido PJ, Armitage J. Toxoplasmosis in pediatric recipients of heart transplants. Clin Infect Dis 1992;14:847-51.
15. Derouin F, Devergie A, Auber P, et al. Toxoplasmosis in bone marrow-transplant recipients: report of seven cases and review. Clin Infect Dis 1992;15:267-70.
16. Hirsh R, Burke BA, Kersey JH. Toxoplasmosis in bone marrow transplant recipients. J Pediatr 1984;105:426-8.
17. Fisher MA, Levy J, Helfrich M, August CS, Starr SE, Luft BJ. Detection of Toxoplasma gondii in the spinal fluid of a bone marrow transplant recipient. Pediatr Infect Dis 1987;6:81-3.
18. Connor E, Menegus M, Cecalupo A, Gigliotti F. Central nervous system toxoplasmosis mimicking a brain abscess in a compromised pediatric patient. Pediatr Infect Dis 1984;3: 552-5.
19. Townsend JJ, Wolinsky JS, Baringer JR, Johnson PC. Acquired Toxoplasmosis: A neglected cause of treatable nervous system disease. Arch Neurol 1975;32:335-43.
20. Carey RM, Kimball AC, Armstrong D, Lieberman PH. Toxoplasmosis: clinical experiences in a cancer hospital. Am J Med 1973;54:30-8.
21. Emerson RG, Jardine DS, Milvenan ES, et al. Toxoplasmosis: a treatable neurologic disease in the immunologically compromised patient. Pediatrics 1981;67:653-5.
22. Hakes TB, Armstrong D. Toxoplasmosis: problems in diagnosis and treatment. Cancer 1983;52:1535-40.
23. Abell C, Holland P. Acute toxoplasmosis complicating leukemia: diagnosis by bone marrow aspiration. Am J Dis Child 1969;118:782-7.
24. Giumarães FN. Toxoplasmose humana. Mem Inst Oswaldo Cruz 1943;38:257-314.
25. Marchan B, Robert A, Mouls JL, Regnier C. Neurotoxoplasmosis in the immunosuppressed child: apropos of 2 cases. Pediatrie 1983;38:319-23.
26. O'Reilly MJJ. Acquired toxoplasmosis: an acute fatal case in a young girl. Med J Aust 1954;2:968-9.
27. Bertrand Y, Fegueux N, Rod'ere M, Jean R. Fatal cerebral toxoplasmosis in a leukemic child in remission. Arch Fr Pediatr 1988;45:346-8.
28. Stagno S, Dykes AC, Amos CS, Head RA, Juranek DD, Walls K. An outbreak of toxoplasmosis linked to cats. Pediatrics 1980;65:706-11.
29. Vukmirovits G, Juhasz P, Janko M, Toth L. Acute monosymptomatic aseptic meningitis caused by Toxoplasma gondii. Acta Paedriatr Hung 1985;26:31-4.
30. Cottrell AJ. Acquired Toxoplasma encephalitis. Arch Dis Child 1986;61:84-5.
31. Mazer S, Araujo JC, Ribeiro RC, Kasting G. Unusual computed tomographic presentation of cerebral toxoplasmosis. AJNR 1983;4:458-60.
32. Triki A, Couvreur J. Les manifestations neuro-méningées de la toxoplasmose acquise. Tunis Med 1971;49:323-9.
33. Shepp DH, Hackman RC, Conley FK, Anderson JB, Meyers JD. Toxoplasma gondii reactivation identified by detection of parasitemia in tissue culture. Ann Intern Med 1985;103:218-21.
34. Lunde MN, Gelderman AH, Hayes SL, Vogel CL. Serologic diagnosis of active toxoplasmosis complicating malignant diseases: usefulness of IgM antibodies and gel-diffusion. Cancer 1970;25:637-43.
35. Thomas TT, Harb JM, Dunne MW, et al. Cerebral toxoplasmosis in an immunocompromised host: a precise and rapid diagnosis by electron microscopy. Am J Clin Pathol 1986;85: 104-10.
36. Bergin M, Menser MA, Procopis PG, Roy LP, Shaw PJ, Stevens MM. Central nervous system toxoplasmosis and hemolytic uremic syndrome. N Engl J Med 1987;317:1540-1.
37. Mclean RG, Murray IPC. Gallium scintigraphy in cerebral toxoplasmosis. Clin Nucl Med 1984;9:592-3.
38. Feldman HA, Sabin AB. Skin reactions to toxoplasmic antigen in people of different ages without known history of infection. Pediatrics 1949;4:798-804.
39. Feldman HA, Miller LT. Serological study of toxoplasmosis prevalence. Am J Hyg 1956;64:320-35.
40. Akstein RB, Wilson LA, Teutsch SM. Acquired toxoplasmosis. Ophthalmology 1982;89:1299-302.
41. Desguerre I, Ponsot G. Acquired cerebral toxoplasmosis in an non-immunosuppressed child. Arch Fr Pediatr 1993;50:339-42.
42. Luft BJ, Remington JS. Toxoplasmic encephalitis. J Infect Dis 1988;157:1-6.
43. Luft BJ, Hafner R, Korzun AH, et al. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1993;329:995-1000.
44. Frenkel JK. Effects of cortisone, total body irradiation, and nitrogen mustard on chronic, latent toxoplasmosis. Am J Pathol 1957;33:618-9.
45. Frenkel JK, Nelson BM, Arias-Stella J. Immunosuppression and toxoplasmic encephalitis: clinical and experimental aspects. Hum Pathol 1975;6:97-111.
46. Masher Am. Infection in the acquired immunodeficiency syndrome, pp94-6. In: Fauci AS, moderator. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. Ann Intern Med 1984;100: 92-106.
47. Masher Am. Infection in the acquired immunodeficiency syndrome, pp94-6. In: Fauci AS, moderator. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. Ann Intern Med 1984;100: 92-106.
48. Suzuki Y, Joh K, Orellana MA, Conley FK, Remington JS. A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice. Immunology 1991;74: 732-9.
49. Miller MJ, Remington JS. Toxoplasmosis in infants and children with HIV infection or AIDS. In: Pizzo PA, Wilfert CM. eds. Pediatric AIDS: the challenge of HIV infection in infants, children, and adolescents. 2nd ed. Baltimore: William & Wilkins, 1994:424-6.
50. Gagliuso DJ, Orellana J. Ocular toxoplasmosis in AIDS patients. Tr Am Ophthalmol Soc 1990;88:63-86.
51. Biggemann B, Neuen E, Kramer H, et al. Neurological manifestations in three German children with AIDS. Neuropediatrics 1987;18:99-106.
52. Shanks GD, Redfield RR, Fischer GW. Toxoplasma encephalitis in an infant with AIDS. Pediatr Infect Dis 1987;6:70-1.
53. Desmonts G, Naot Y, Remington JS. Immunoglobulin M-immunosorbent agglutination assay for diagnosis of infectious disease: diagnosis of acute congenital and acquired Toxoplasma infections. J Clin Microbiol 1981;14:486-91.
54. Stepick-Biek P, Thulliez P, Araujo FG, Remington JS. IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis. J Infect Dis 1990;162:270-3.
55. Wong SY, Hajdu MP, Ramirez R, Thulliez P, McLeod R, Remington JS. Role of specific immunoglobulin E in diagnosis of acute Toxoplasma infection and toxoplasmosis. J Clin Microbiol 1993;31:2952-9.
56. Cohn JA, McKeeking A, Cohen W, Jacobs J, Holzman RS. Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome. Am J Med 1989;86:521-7.
57. Just M, Higer HP, Krämer G, et al. Magnetic resonance imaging in infections of the brain: findings in tuberculosis, listeriosis, toxoplasmosis, subacute sclerosing panencephalitis, and multiple sclerosis. Neurosurg Rev 1987;10:185-90.
58. Wilson CB, Remington JS. Toxoplasmosis. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases. 3rd ed. Philadelphia: Saunders, 1992:2057-69.
59. Dannemann BR, Israelski DM, Remington JS. Treatment of toxoplasmic encephalitis with intravenous clindamycin. Arch Intern Med 1988;148:2477-82.
60. Hofflin JM, Remington JS. In vivo synergism of roxithromycin (RU965) and interferon against Toxoplasma gondii. Antimicrob Agents Chemother 1987;31:346-8.
61. Arauyo FG, Remington JS. Azithromycin: a macrolide antibiotic with potent activity against Toxoplasma gondii. Antimicrob Agents Chemother 1988;32:755-7.
62. Kovacs JA, Altegra JC, Chabner BA, et al. Potent effect of trimetrexate, a lipid-soluble antifolate on Toxoplasma gondii. J Infect Dis 1987;155:1027-32.